Development of a T cell-redirecting bispecific antibody targeting B-cell maturation antigen for the suppression of multiple myeloma cell growth

BACKGROUND: Multiple myeloma (MM) is the second most common hematological malignancy. It has emerged as one of the next possible hematological diseases amenable to immunotherapy. B-cell maturation antigen (BCMA), a member of the tumor necrosis factor receptor superfamily, is highly expressed in MM c...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Jianxin, Huang, Yuhan, Zheng, Ziying, Tay, Xin Ni, Mahfut, Farouq Bin, Zhang, Wei, Lam, Kong-Peng, Yang, Yuansheng, Xu, Shengli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Bispecific Antibody CMC
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237814/
https://www.ncbi.nlm.nih.gov/pubmed/35774245
http://dx.doi.org/10.1093/abt/tbac012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237814/
https://www.ncbi.nlm.nih.gov/pubmed/35774245
http://dx.doi.org/10.1093/abt/tbac012

Ejemplares similares